Stocks360

Laboratorio Reig Jofre, S.A. (RJF.MC)

Stock analysis · BME · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.94
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Laboratorio Reig Jofre, S.A. (RJF.MC) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Laboratorio Reig Jofre, S.A.

Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap